A citation-based method for searching scientific literature

Giuseppe M C Rosano, Basil Lewis, Stefan Agewall, Sven Wassmann, Cristiana Vitale, Harald Schmidt, Heinz Drexel, Atul Patak, Christian Torp-Pedersen, Keld Per Kjeldsen, Juan Tamargo. Eur Heart J 2015
Times Cited: 77







List of co-cited articles
534 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sex differences in pharmacokinetics and pharmacodynamics.
Offie P Soldin, Donald R Mattison. Clin Pharmacokinet 2009
443
27

Sex-based differences in the effect of digoxin for the treatment of heart failure.
Saif S Rathore, Yongfei Wang, Harlan M Krumholz. N Engl J Med 2002
403
20

Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
16

Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study.
Bernadet T Santema, Wouter Ouwerkerk, Jasper Tromp, Iziah E Sama, Alice Ravera, Vera Regitz-Zagrosek, Hans Hillege, Nilesh J Samani, Faiez Zannad, Kenneth Dickstein,[...]. Lancet 2019
91
16

Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes.
Vera Regitz-Zagrosek, Sabine Oertelt-Prigione, Eva Prescott, Flavia Franconi, Eva Gerdts, Anna Foryst-Ludwig, Angela H E M Maas, Alexandra Kautzky-Willer, Dorit Knappe-Wegner, Ulrich Kintscher,[...]. Eur Heart J 2016
335
15


Gender differences in the effects of cardiovascular drugs.
J Tamargo, G Rosano, T Walther, J Duarte, A Niessner, J C Kaski, C Ceconi, H Drexel, K Kjeldsen, G Savarese,[...]. Eur Heart J Cardiovasc Pharmacother 2017
122
14

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials.
Paul G Shekelle, Michael W Rich, Sally C Morton, Col Sid W Atkinson, Wenli Tu, Margaret Maglione, Shannon Rhodes, Michael Barrett, Gregg C Fonarow, Barry Greenberg,[...]. J Am Coll Cardiol 2003
334
12

Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs.
Pamela E Scott, Ellis F Unger, Marjorie R Jenkins, Mary Ross Southworth, Tzu-Yun McDowell, Ruth J Geller, Merina Elahi, Robert J Temple, Janet Woodcock. J Am Coll Cardiol 2018
140
12

Representation of women in randomized clinical trials of cardiovascular disease prevention.
Chiara Melloni, Jeffrey S Berger, Tracy Y Wang, Funda Gunes, Amanda Stebbins, Karen S Pieper, Rowena J Dolor, Pamela S Douglas, Daniel B Mark, L Kristin Newby. Circ Cardiovasc Qual Outcomes 2010
264
11

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
Bertram Pitt, Willem Remme, Faiez Zannad, James Neaton, Felipe Martinez, Barbara Roniker, Richard Bittman, Steve Hurley, Jay Kleiman, Marjorie Gatlin. N Engl J Med 2003
11


Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Scott D Solomon, John J V McMurray, Inder S Anand, Junbo Ge, Carolyn S P Lam, Aldo P Maggioni, Felipe Martinez, Milton Packer, Marc A Pfeffer, Burkert Pieske,[...]. N Engl J Med 2019
793
11

Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases.
Nicoline Jochmann, Karl Stangl, Edeltraut Garbe, Gert Baumann, Verena Stangl. Eur Heart J 2005
158
10

Representation of the elderly, women, and minorities in heart failure clinical trials.
Asefeh Heiat, Cary P Gross, Harlan M Krumholz. Arch Intern Med 2002
497
10

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
10


Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Lerebours, Luigi Tavazzi. Lancet 2010
9

Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
A B Luzier, A Killian, J H Wilton, M F Wilson, A Forrest, D J Kazierad. Clin Pharmacol Ther 1999
107
9

Gender differences in advanced heart failure: insights from the BEST study.
Jalal K Ghali, Heidi J Krause-Steinrauf, Kirkwood F Adams, Steven S Khan, Yves D Rosenberg, Clyde W Yancy, James B Young, Steven Goldman, Mary Ann Peberdy, JoAnn Lindenfeld. J Am Coll Cardiol 2003
210
9

Gender is an important determinant of the disposition of the loop diuretic torasemide.
Ulrike Werner, Dierk Werner, Svetlana Heinbüchner, Bernhard Graf, Hüseyin Ince, Stefan Kische, Petra Thürmann, Jörg König, Martin F Fromm, Oliver Zolk. J Clin Pharmacol 2010
29
24


The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
M Packer, M R Bristow, J N Cohn, W S Colucci, M B Fowler, E M Gilbert, N H Shusterman. N Engl J Med 1996
9


Eplerenone in patients with systolic heart failure and mild symptoms.
Faiez Zannad, John J V McMurray, Henry Krum, Dirk J van Veldhuisen, Karl Swedberg, Harry Shi, John Vincent, Stuart J Pocock, Bertram Pitt. N Engl J Med 2011
9

Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.
Anna L Beale, Philippe Meyer, Thomas H Marwick, Carolyn S P Lam, David M Kaye. Circulation 2018
168
9

Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women: A Systematic Review of the Literature.
Sophie H Bots, Floor Groepenhoff, Anouk L M Eikendal, Cara Tannenbaum, Paula A Rochon, Vera Regitz-Zagrosek, Virginia M Miller, Danielle Day, Folkert W Asselbergs, Hester M den Ruijter. JACC Heart Fail 2019
30
23

Cardiovascular Disease in Women: Clinical Perspectives.
Mariana Garcia, Sharon L Mulvagh, C Noel Bairey Merz, Julie E Buring, JoAnn E Manson. Circ Res 2016
427
7

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
Salim Yusuf, Steven Hawken, Stephanie Ounpuu, Tony Dans, Alvaro Avezum, Fernando Lanas, Matthew McQueen, Andrzej Budaj, Prem Pais, John Varigos,[...]. Lancet 2004
7

Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines.
Marie Manteuffel, Sophy Williams, William Chen, Robert R Verbrugge, Donald G Pittman, Amy Steinkellner. J Womens Health (Larchmt) 2014
182
7



Lifetime risk for developing congestive heart failure: the Framingham Heart Study.
Donald M Lloyd-Jones, Martin G Larson, Eric P Leip, Alexa Beiser, Ralph B D'Agostino, William B Kannel, Joanne M Murabito, Ramachandran S Vasan, Emelia J Benjamin, Daniel Levy. Circulation 2002
7

Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.
Emelia J Benjamin, Salim S Virani, Clifton W Callaway, Alanna M Chamberlain, Alexander R Chang, Susan Cheng, Stephanie E Chiuve, Mary Cushman, Francesca N Delling, Rajat Deo,[...]. Circulation 2018
7

Sex differences in immune responses.
Sabra L Klein, Katie L Flanagan. Nat Rev Immunol 2016
7

Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis.
Manuel Martínez-Sellés, Robert N Doughty, Katrina Poppe, Gillian A Whalley, Nikki Earle, Christophe Tribouilloy, John J V McMurray, Karl Swedberg, Lars Køber, Colin Berry,[...]. Eur J Heart Fail 2012
124
7

Sex-based differences in drug activity.
Heather Whitley, Wesley Lindsey. Am Fam Physician 2009
85
7

Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women.
Pooja Dewan, Rasmus Rørth, Pardeep S Jhund, Li Shen, Valeria Raparelli, Mark C Petrie, William T Abraham, Akshay S Desai, Kenneth Dickstein, Lars Køber,[...]. J Am Coll Cardiol 2019
96
7

Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.
Carolyn S P Lam, Peter E Carson, Inder S Anand, Thomas S Rector, Michael Kuskowski, Michel Komajda, Robert S McKelvie, John J McMurray, Michael R Zile, Barry M Massie,[...]. Circ Heart Fail 2012
121
7

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.
Jordan Fulcher, Rachel O'Connell, Merryn Voysey, Jonathan Emberson, Lisa Blackwell, Borislava Mihaylova, John Simes, Rory Collins, Adrienne Kirby, Helen Colhoun,[...]. Lancet 2015
763
6


Sex differences in drug disposition.
Offie P Soldin, Sarah H Chung, Donald R Mattison. J Biomed Biotechnol 2011
158
6

Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis.
Kirkwood F Adams, J Herbert Patterson, Wendy A Gattis, Christopher M O'Connor, Craig R Lee, Todd A Schwartz, Mihai Gheorghiade. J Am Coll Cardiol 2005
157
6

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.
Marc A Pfeffer, Karl Swedberg, Christopher B Granger, Peter Held, John J V McMurray, Eric L Michelson, Bertil Olofsson, Jan Ostergren, Salim Yusuf, Stuart Pocock. Lancet 2003
6

Sex differences in pharmacokinetics and pharmacodynamics.
Monica Gandhi, Francesca Aweeka, Ruth M Greenblatt, Terrence F Blaschke. Annu Rev Pharmacol Toxicol 2004
315
6

Effect of carvedilol on survival in severe chronic heart failure.
M Packer, A J Coats, M B Fowler, H A Katus, H Krum, P Mohacsi, J L Rouleau, M Tendera, A Castaigne, E B Roecker,[...]. N Engl J Med 2001
6

Management of patients with heart failure in clinical practice: differences between men and women.
M J Lenzen, A Rosengren, W J M Scholte op Reimer, F Follath, E Boersma, M L Simoons, J G F Cleland, M Komajda. Heart 2008
66
7

Adverse effects in women: implications for drug development and regulatory policies.
Ameeta Parekh, Emmanuel O Fadiran, Kathleen Uhl, Douglas C Throckmorton. Expert Rev Clin Pharmacol 2011
59
8

Epidemiology of heart failure with preserved ejection fraction.
Shannon M Dunlay, Véronique L Roger, Margaret M Redfield. Nat Rev Cardiol 2017
493
6

Long-term trends in the incidence of and survival with heart failure.
Daniel Levy, Satish Kenchaiah, Martin G Larson, Emelia J Benjamin, Michelle J Kupka, Kalon K L Ho, Joanne M Murabito, Ramachandran S Vasan. N Engl J Med 2002
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.